Evidence map›Paper›PMID 42706256›Full record

ArticleBone research2026

Fibroblast growth factor receptor signaling in maturing osteoblasts controls cell-matrix interactions critical for osteocyte survival.

Debabrata Patra, Craig Smith, Chenming Wei, Courtney M Mazur, Ilemona Ameadaji, Tiandao Li, Marc N Wein, Matthew J Silva, David M Ornitz

Abstract read
In one paragraph

Article in Bone research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Debabrata PatraDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0001-8606-1573
Craig SmithDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA.
Chenming WeiDepartment of Orthopaedic Surgery, Washington University School of Medicine and McKelvey School of Engineering, Washington University, St. Louis, MO, USA.ORCID http://orcid.org/0009-0008-1558-0091
Courtney M MazurEndocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1143-5483
Ilemona AmeadajiDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA.
Tiandao LiDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA.
Marc N WeinEndocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6015-8147
Matthew J SilvaDepartment of Orthopaedic Surgery, Washington University School of Medicine and McKelvey School of Engineering, Washington University, St. Louis, MO, USA.
David M OrnitzDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA. dornitz@wustl.edu.ORCID http://orcid.org/0000-0003-1592-7629

Funding

TRAINING PROGRAM IN ENDOCRINOLOGY AND DIABETEST32DK007028 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Karen K Miller · 1986 to 2026
$18.5M
The role of salt inducible kinases in parathyroid hormone action in boneR01DK116716 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Marc Nathan Wein · 2018 to 2026
$3.8M
Regulation of Osteocyte Survival by Fibroblast Growth Factor Signaling PathwaysR01AR079246 · NIAMS · WASHINGTON UNIVERSITY · PI David M Ornitz · 2022 to 2026
$2.5M
The Dynamic Range of Site-1 Protease Functions in Skeletal DevelopmentR01AR066590 · NIAMS · WASHINGTON UNIVERSITY · PI PATRA, DEBABRATA, SANDELL, LINDA J · 2015 to 2019
$1.7M
Trafficking and translation of mRNA in osteocyte dendritesF32AR081660 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI MAZUR, COURTNEY MARISA · 2022 to 2024
$91k
NIAMS NIH HHS F32 AR081660NIAMS NIH HHS R01 AR066590NIAMS NIH HHS R01 AR079246NIDDK NIH HHS R01 DK116716NIDDK NIH HHS T32 DK007028U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR081660U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01 AR066590U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01 AR079246U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) DK007028U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R01 DK116716
6 · The paper itself

Abstract

The terminal differentiation of osteoblasts into osteocytes, the most abundant cell type in cortical bone, is critical for skeletal homeostasis. Osteocyte loss is a hallmark of bone aging and fragility, yet the mechanisms regulating osteocyte formation and survival are poorly understood. We show that inactivation of fibroblast growth factor receptor 1 (Fgfr1) in the mature osteoblast lineage results in extensive osteocyte death, identifying FGFR1 signaling as essential for osteocyte viability and bone integrity. Lineage tracing and analysis of endogenous and induced appositional bone formation revealed that newly embedded osteocytes fail to survive without FGFR1. These osteocytes exhibited ectopic expression of osteocalcin and podoplanin within sclerostin-positive, TUNEL-reactive lacunae, along with defective dendrite formation and disruption of the local lacunocanalicular network. RNA sequencing of cortical bone demonstrated reduced expression of extracellular matrix (ECM) genes and neuronal regulatory genes, while histological and ultrastructural analyses showed disorganized collagen fibrils, diminished osteoid, and abnormal mineralization. In vitro, FGF signaling in Ocy454 cells regulated gene programs involved in development, axon guidance, and bone ECM organization, highlighting a dual function for FGF signaling in which it controls both matrix-dependent and intrinsic cell differentiation mechanisms during the osteoblast-to-osteocyte transition. We propose that FGFR1 deficiency causes ECM disorganization and impaired dendrite formation, disrupting osteocyte communication with neighboring bone and vascular cells, ultimately leading to cell death. These findings establish FGFR signaling as a critical regulator of osteocyte differentiation, viability of bone-embedded osteocytes, and bone homeostasis.

Indexed as

Extracellular MatrixOsteoblastsOsteocytesReceptor, Fibroblast Growth Factor, Type 1Receptors, Fibroblast Growth FactorSignal TransductionAnimalsCell DifferentiationCell SurvivalMiceOsteogenesisReceptor, Fibroblast Growth Factor, Type 1Receptors, Fibroblast Growth Factor

Identifiers

PMID42706256
PMCPMC13550433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.